![Mao Yonghui, Beijing Hospital](https://marketing.webassets.siemens-healthineers.com/dfcc377efe613139/9fb3e7e18ae9/v/3a059ef458f9/siemens-healthineers_plasma-proteins_mao-yonghui.jpg)
Speaker:
Dr. Mao Yonghui
Dept. of Nephrology
Beijing Hospital, China
FLC testing in multiple myeloma and kidney disease: A Chinese Perspective
Multiple myeloma (MM) is one of the most common blood cancers, often involving impaired kidney function. Free light chains (FLC) testing is a guideline-recommended cornerstone in the diagnosis, monitoring, and disease management of MM. This session explores the current role of FLC testing in MM, and considers the influence of kidney function on FLC test result. Dr. Mao Yonghui shares a Chinese perspective on this important subject.
Speaker:
Dr. Mao Yonghui
Dept. of Nephrology
Beijing Hospital, China
Subscribe to news from Siemens Healthineers UK and Ireland
Keep up to date on the latest trends in healthcare. Read about current developments, new products and upcoming events.